Markers of endothelial dysfunction and severity of hypoxaemia in the Eisenmenger syndrome

Endothelial dysfunction has been reported in hypoxaemic patients with the Eisenmenger syndrome, but a direct correlation between levels of endothelial markers and the severity of hypoxaemia has not been explored. With this in mind, we compared the levels in the plasma of tissue-type plasminogen activator, thrombomodulin, and von Willebrand factor in 25 patients with the Eisenmenger syndrome. They had a median age of 31 years, and were divided into 2 groups according to their recent clinical history. Thus, 18 patients were stable, being in functional class II or III, seen as outpatients, and having peripheral saturations of oxygen of 89 plus or minus 5 percent. In contrast, 7 patients were unstable, showing episodes of symptoms placing them in functional class IV, requiring care in hospital, and manifesting saturations of oxygen of 77 plus or minus 5 percent. We were able to follow 12 patients, 8 who were stable and 4 unstable, for 24 months. At baseline, levels of von Willebrand factor were higher in the unstable patients when compared to those who were stable, at 142 plus or minus 29 and 110 plus or minus 25 units per decilitre, respectively (p equal to 0.013). This correlated positively with oxygen desaturation (p less than 0.020). The structural abnormalities also correlated positively with the magnitude of hypoxaemia (p less than 0.020). Levels remained higher in the unstable patients throughout the period of follow-up (p equal to 0.006). Tissue-type plasminogen activator was also increased, at 14.3 plus or minus 8.4 versus 6.5 plus or minus 2.7 nanograms per millilitre in controls (p less than 0.001), whereas thrombomodulin was decreased, with values of 14.4 versus 34.6 nanograms per millilitre in controls (p for median values of less than 0.001). There was no correlation with saturations of oxygen. We conclude that measurement of von Willebrand factor, as compared with tissue-type plasminogen activator and thrombomodulin, will prove a better marker of endothelial response to hypoxaemia in patients with the Eisenmenger syndrome.

[1]  Y. Fung,et al.  Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. , 2004, Microvascular research.

[2]  A. Lopes,et al.  Age-Dependent Likelihood of In Situ Thrombosis in Secondary Pulmonary Hypertension , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[3]  M. Humbert,et al.  Cellular and molecular pathobiology of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[4]  J. Moake,et al.  P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. , 2004, Blood.

[5]  C. Silversides,et al.  Pulmonary thrombosis in adults with Eisenmenger syndrome. , 2003, Journal of the American College of Cardiology.

[6]  E. Hart,et al.  Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. , 2003, The American journal of cardiology.

[7]  H. Horigome,et al.  Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis. , 2003, Thrombosis research.

[8]  Kazuo Fujikawa,et al.  ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. , 2002, Blood.

[9]  A. Lopes,et al.  A mathematical framework for group analysis of von Willebrand factor multimeric composition following luminography. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[10]  J. Pimanda,et al.  Control of von Willebrand factor multimer size and implications for disease. , 2002, Blood reviews.

[11]  K. Kubo,et al.  Positive Association of the Endothelial Nitric Oxide Synthase Gene Polymorphisms With High-Altitude Pulmonary Edema , 2002, Circulation.

[12]  H. Oberleithner,et al.  Secretion Pores in Human Endothelial Cells during Acute Hypoxia , 2002, The Journal of Membrane Biology.

[13]  E. Kruithof,et al.  Synergistic Induction of t-PA by Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor and Localization of t-PA to Weibel-Palade Bodies in Bovine Microvascular Endothelial Cells , 2001, Thrombosis and Haemostasis.

[14]  P. D. da Luz,et al.  Influence of Hypoxia on Nitric Oxide Synthase Activity and Gene Expression in Children With Congenital Heart Disease: A Novel Pathophysiological Adaptive Mechanism , 2001, Circulation.

[15]  A. Sala,et al.  Proteolysis of von Willebrand Factor and Shear Stress–Induced Platelet Aggregation in Patients With Aortic Valve Stenosis , 2000, Circulation.

[16]  J. Remacle,et al.  Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. , 2000, Biochimica et biophysica acta.

[17]  G. Breithardt,et al.  Abundance of Microembolic Signals Detected by Transcranial Doppler Ultrasound in a Patient with Eisenmenger’s Syndrome , 1999, Cerebrovascular Diseases.

[18]  H. Rayburn,et al.  Intravascular coagulation activation in a murine model of thrombomodulin deficiency: effects of lesion size, age, and hypoxia on fibrin deposition. , 1998, Blood.

[19]  J. Piette,et al.  Plasma levels of thrombomodulin in pulmonary hypertension. , 1996, The American journal of medicine.

[20]  T. Mayadas,et al.  Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. , 1996, The Journal of clinical investigation.

[21]  S. Archer,et al.  The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  D. Pinsky,et al.  Hypoxic induction of interleukin-8 gene expression in human endothelial cells. , 1994, The Journal of clinical investigation.

[23]  D. Faller,et al.  Oxygen tension regulates neutrophil adhesion to human endothelial cells via an LFA‐1‐dependent mechanism , 1993, Journal of cellular physiology.

[24]  A. Carayon,et al.  Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. , 1993, The American journal of cardiology.

[25]  H. Niwano,et al.  Circulating thrombomodulin as a novel endothelial cell marker: Comparison of its behavior with von willebrand factor and tissue‐type plasminogen activator , 1992, American journal of hematology.

[26]  H. Lieberman,et al.  Macrovascular and microvascular endothelium during long‐term hypoxia: Alterations in cell growth, monolayer permeability, and cell surface coagulant properties , 1991, Journal of cellular physiology.

[27]  H. Gerlach,et al.  Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. , 1990, The Journal of clinical investigation.

[28]  C. Esmon,et al.  The roles of protein C and thrombomodulin in the regulation of blood coagulation. , 1984, The Journal of biological chemistry.